Barclays’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.3K Hold
805
– – ﹤0.01% 4583
2026
Q1
$20.3K Buy
+805
New +$20.5K ﹤0.01% 4573
2025
Q4
– Sell
-19,470
Closed -$499K – 5425
2025
Q3
$499K Buy
+19,470
New +$494K ﹤0.01% 3811

Other funds holding IBDX

Barclays's IBDX Position: Q2 2026 in Review

Barclays held its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) position steady in Q2 2026 at 805 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4583.

Barclays first reported a position in IBDX in Q3 2025 and has held it in 3 quarters since. The position peaked at $499K in Q3 2025. 229 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Barclays held 805 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $20.3K as of Q2 2026.
  • Barclays left its iShares iBonds Dec 2032 Term Corporate ETF share count unchanged in Q2 2026.
  • iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4583 holding.
  • Barclays first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and has held it in 3 quarters since.
  • Barclays's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $499K in Q3 2025.
  • 229 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.